Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

SUCCESSFUL CLOSURE OF FULL-THICKNESS MACULAR HOLES SECONDARY TO MACULAR VITELLIFORM LESIONS

Galvin, Justin C., BSc (Hons I)*; Chua, Brian E., MBBS (Hons) BSc, MPH (Hons), FRANZCO†,‡; Fung, Adrian T., MBBS (Hons I), MMed (Ophthalmic Science, Clinical Epidemiology), FRANZCO‡,§,¶

Retinal Cases and Brief Reports: July 2019 - Volume 13 - Issue 3 - p 199–201
doi: 10.1097/ICB.0000000000000566
Case Report
Buy

Purpose: To describe the first reported cases of full-thickness macular holes secondary to vitelliform lesions that were successfully closed with vitrectomy surgery and gas tamponade.

Methods: Two female patients developed visual loss secondary to bilateral vitelliform lesions and associated full-thickness macular holes. The patients underwent 25-gauge pars plana vitrectomy, internal limiting membrane peeling, and 26% sulfur hexafluoride gas, followed by 3 days of face-down positioning.

Results: In both patients, the macular holes remain closed 3 and 25 months postoperatively.

Conclusion: Vitrectomy surgery with gas tamponade may successfully close full-thickness macular holes secondary to macular vitelliform lesions.

The authors describe the first reported cases of successful closure of full-thickness macular holes secondary to vitelliform lesions, after vitrectomy surgery and gas tamponade.

*Deakin University, Geelong, Victoria, Australia;

Sydney Hospital, Sydney Eye Hospital, Sydney, New South Wales, Australia;

Department of Ophthalmology, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia;

§Save Sight Institute, University of Sydney, Sydney, New South Wales, Australia; and

Department of Ophthalmology, Westmead Hospital, Sydney, New South Wales, Australia.

Reprint requests: Adrian T. Fung, MBBS (Hons I), MMed (Ophthalmic Science, Clinical Epidemiology), FRANZCO, Retina & Macular Specialists, 1A/12 Central Road, Miranda, NSW 2228, Australia; e-mail: adrianfungi@yahoo.com.au

None of the authors has any financial/conflicting interests to disclose.

© 2019 by Ophthalmic Communications Society, Inc.